Neurocrine Biosciences
NBIX
#1505
Rank
โ‚น992.53 B
Marketcap
โ‚น9,955
Share price
0.50%
Change (1 day)
-14.91%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

EPS for Neurocrine Biosciences (NBIX)

EPS in 2023 (TTM): โ‚น162.41

According to Neurocrine Biosciences 's latest financial reports the company's current EPS (TTM) is โ‚น167.94. In 2022 the company made an earnings per share (EPS) of โ‚น137.95 an increase over its 2021 EPS that were of โ‚น81.40.

EPS history for Neurocrine Biosciences from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น162.4117.73%
2022โ‚น137.9569.47%
2021โ‚น81.40-78.21%
2020โ‚น373.59990%
2019โ‚น34.2781.82%
2018โ‚น18.85-113.5%
2017-โ‚น139.670.62%
2016-โ‚น138.8157.28%
2015-โ‚น88.2625.61%
2014-โ‚น70.2618.84%
2013-โ‚น59.12-1085.71%
2012โ‚น6.00-89.71%
2011โ‚น58.27-500%
2010-โ‚น14.57-86.92%
2009-โ‚น111.39-43.48%
2008-โ‚น197.08-57.8%
2007-โ‚น466.9892.58%
2006-โ‚น242.49371.67%
2005-โ‚น51.41-52.76%
2004-โ‚น108.8236.56%
2003-โ‚น79.69-70%
2002-โ‚น265.62118.31%
2001-โ‚น121.678.4%
2000-โ‚น112.2548.86%
1999-โ‚น75.40-20%
1998-โ‚น94.25-479.31%
1997โ‚น24.85

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น179.08 6.63%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น47.13-71.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
-โ‚น253.63-251.02%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น465.21 177.00%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น315.38 87.79%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น159.37-5.10%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น40.27-123.98%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น259.63-254.59%๐Ÿ‡บ๐Ÿ‡ธ USA